Purinergic P2X7 Receptors Participate in Disturbed Intracellular Calcium Homeostasis in Peripheral Blood Mononuclear Cells of Patients with Chronic Kidney Disease

被引:12
|
作者
Lajdova, Ingrid [1 ]
Oksa, Adrian [1 ]
Chorvat, Dusan, Jr. [2 ]
Topor, Peter [2 ]
Spustova, Viera [1 ]
机构
[1] Slovak Med Univ, Dept Clin & Expt Pharmacol, Fac Med, SK-03303 Bratislava, Slovakia
[2] Ctr Int Laser, Dept Biophoton, Bratislava, Slovakia
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2012年 / 35卷 / 01期
关键词
P2X(7) receptors; Intracellular calcium; Chronic kidney disease; Human lymphocytes; ATPASE ACTIVITY; RENAL-DISEASE; OF-FUNCTION; EXPRESSION; POLYMORPHISM; MODULATION; INFLUX; CA2+;
D O I
10.1159/000330349
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background: P2X(7) receptors intervene with lymphocyte activation and are responsible for multiple processes, including calcium influx. Here, we studied the participation of P2X(7) receptors in disturbed intracellular calcium homeostasis regulation in early-stage chronic kidney disease (CKD). Methods: The study involved 20 healthy volunteers and 20 CKD stage 2-3 patients. The free cytosolic calcium concentration ([Ca2+](i)) was measured using fluorimetry. The P2X(7) pore function was evaluated by the fluorescent dye ethidium bromide. Results: In peripheral blood mononuclear cells (PBMCs) of patients, [Ca2+](i), intracellular calcium stores and the capacitative calcium entry were increased when compared with healthy subjects. The agonist of P2X(7) receptor BzATP caused a sustained increase in [Ca2+](i) in both groups, but the effect was smaller in patients. The antagonist at the P2X(7) receptor KN-62 reduced [Ca2+](i) in patients, but had no effect in healthy subjects. In patients, the permeability of ethidium bromide through P2X(7) pores, as well as through BzATP-activated and KN-62-inhibited pores, was distinct from permeability in healthy volunteers. Conclusions:These results demonstrate that the calcium signaling pathway in PBMCs of CKD patients is defective already in CKD stage 2-3, and the pore-forming P2X(7) receptors are involved in these pathophysiological processes. copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:48 / 57
页数:10
相关论文
共 50 条
  • [31] Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner
    Amini, Maryam
    Frisch, Janina
    Jost, Priska
    Sarakpi, Tamim
    Selejan, Simina-Ramona
    Becker, Ellen
    Sellier, Alexander
    Engel, Jutta
    Hohl, Mathias
    Noels, Heidi
    Maack, Christoph
    Schunk, Stefan
    Roma, Leticia Prates
    Niemeyer, Barbara A.
    Speer, Thimoteus
    Alansary, Dalia
    KIDNEY INTERNATIONAL, 2025, 107 (03) : 457 - 475
  • [32] P2X7 purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability
    Placido, Roberta
    Auricchio, Giovanni
    Falzoni, Simonetta
    Battistini, Luca
    Colizzi, Vittorio
    Brunetti, Ercole
    Di Virgilio, Francesco
    Mancino, Giorgio
    CELLULAR IMMUNOLOGY, 2006, 244 (01) : 10 - 18
  • [33] Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes
    Ruiz-Rodriguez, Victor Manuel
    Turijan-Espinoza, Eneida
    Guel-Panola, Jaime Arturo
    Garcia-Hernandez, Mariana Haydee
    Zermeno-Nava, Jose de Jesus
    Lopez-Lopez, Nallely
    Bernal-Silva, Sofia
    Layseca-Espinosa, Esther
    Fuentes-Panana, Ezequiel M.
    Estrada-Sanchez, Ana Maria
    Portales-Perez, Diana Patricia
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [34] Purinergic receptor (P2X7) activation reduces cell-cell adhesion between tubular epithelial cells of the proximal kidney
    Siamantouras, Eleftherios
    Price, Gareth W.
    Potter, Joe A.
    Hills, Claire E.
    Squires, Paul E.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 22
  • [35] Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis
    Zhang, Yong
    Zhang, Yanyan
    Li, Hao
    Jia, Xiao
    Zhang, Xiuying
    Xia, Yan
    Wang, YuZhong
    Fu, Linlin
    Xiao, Chenghua
    Geng, Deqin
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 157 : 88 - 94
  • [36] Effect of the conditioned medium of mesenchymal stem cells on the expression levels of P2X4 and P2X7 purinergic receptors in the spinal cord of rats with neuropathic pain
    Mahsa Masoodifar
    Saeed Hajihashemi
    Saeed Pazhoohan
    Samad Nazemi
    Mohammad-Shafi Mojadadi
    Purinergic Signalling, 2021, 17 : 143 - 150
  • [37] Effect of the conditioned medium of mesenchymal stem cells on the expression levels of P2X4 and P2X7 purinergic receptors in the spinal cord of rats with neuropathic pain
    Masoodifar, Mahsa
    Hajihashemi, Saeed
    Pazhoohan, Saeed
    Nazemi, Samad
    Mojadadi, Mohammad-Shafi
    PURINERGIC SIGNALLING, 2021, 17 (01) : 143 - 150
  • [38] Selective Upregulation of Pen1 mRNA Expression by ATP Through Activation of P2X7 Purinergic Receptors Expressed in Microglial Cells
    Nakazato, Ryota
    Takarada, Takeshi
    Yamamoto, Tomomi
    Hotta, Shogo
    Hinoi, Eiichi
    Yoneda, Yukio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (04) : 350 - 361
  • [39] Activation of P2X7 Receptors in Peritoneal and Meningeal Mast Cells Detected by Uptake of Organic Dyes: Possible Purinergic Triggers of Neuroinflammation in Meninges
    Nurkhametova, Dilyara
    Kudryavtsev, Igor
    Guselnikova, Valeriia
    Serebryakova, Maria
    Giniatullina, Raisa R.
    Wojciechowski, Sara
    Tore, Fatma
    Rizvanov, Albert
    Koistinaho, Jari
    Malm, Tarja
    Giniatullin, Rashid
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [40] Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease
    Wang, Xin-Hong
    Xie, Xin
    Luo, Xiao-Guang
    Shang, Hong
    He, Zhi-Yi
    MOLECULAR MEDICINE REPORTS, 2017, 15 (02) : 768 - 776